Avastin (Bevacizumab) in the Treatment of Metastatic Colorectal Cancer in Normal Clinical Use in the UK Population
NCT02542436 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2017-09-13
Summary
This study will focus on participants in the United Kingdom (UK) to collect local data on the effectiveness and safety of bevacizumab (Avastin) in the treatment of metastatic colorectal cancer in normal clinical use.
Conditions
Interventions
- OTHER
-
No intervention
No intervention administered in this study
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Clinical Trials · Hoffmann-La Roche
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-01
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
More Related Trials
-
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Cancer of the Colon or Rectum
NCT01830647 ·Status: COMPLETED
-
A Study of Avastin (Bevacizumab) in Combination Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
NCT01131078 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Study of Bevacizumab [Avastin] in Patients With Metastatic Colorectal Cancer (AVASTART)
NCT01089413 ·Status: COMPLETED
-
Observation of Patients With Metastatic Colorectal Cancer Starting Chemotherapy Combined With Bevacizumab (Avastin)
NCT02612077 ·Status: COMPLETED
-
A Real World Study to Evaluate Effectiveness of Avastin (Bevacizumab) for First Line Treatment of Patients With Metastatic Colorectal Cancer and Known KRAS Status
NCT02831842 ·Status: COMPLETED
-
An Observational Study of Avastin in Participants With Metastatic Colorectal Cancer (KORALLE)
NCT01775644 ·Status: COMPLETED
-
A Study of Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer.
NCT00778102 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal Cancer
NCT00114946 ·Status: TERMINATED ·Phase: PHASE4
-
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (RELEVANT)
NCT01697449 ·Status: COMPLETED
-
An Observational Study of First-Line Bevacizumab (Avastin) With Fluoropyrimidine-Based Chemotherapy in Participants With Metastatic Colorectal Cancer
NCT01712347 ·Status: COMPLETED
-
A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum
NCT02582970 ·Status: COMPLETED ·Phase: PHASE4
-
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer: Continued Avastin Plus Chemotherapy After First Progression in Clinical Practice
NCT02287597 ·Status: COMPLETED
-
A Study to Evaluate Avastin in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer
NCT00109226 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer.
NCT00700102 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer.
NCT00642577 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study of Avastin (Bevacizumab) in First Line in Patients With Metastatic Colorectal Cancer (AVANiS)
NCT01674907 ·Status: COMPLETED
-
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer in Italy (BEWARE)
NCT01609075 ·Status: COMPLETED
-
A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer.
NCT01135498 ·Status: COMPLETED ·Phase: PHASE2
-
A Translational Study of Bevacizumab in Participants With Metastatic Colorectal Cancer
NCT01588990 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Avastin (Bevacizumab) in Combination With mFOLFOX6 in Treatment-Naïve Patients With Metastatic Colorectal Cancer With or Without K-RAS Mutations, and Comparison to Cetuximab
NCT01338558 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Study of Bevacizumab (Avastin) in Combination With Capecitabine (Xeloda) in Elderly Patients With Metastatic Colorectal Cancer
NCT00484939 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Avastin in Combination With Standard Chemotherapy to Treat Colorectal Cancer
NCT00109070 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer
NCT01399190 ·Status: COMPLETED
-
Post-First Progression Use of Bevacizumab in Metastatic Colorectal Cancer (mCRC)
NCT00862342 ·Status: COMPLETED ·Phase: PHASE2
-
Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
NCT00826540 ·Status: COMPLETED ·Phase: PHASE2